Changing the schedule of targeted therapies has been shown to improve the response rate in a mouse model of melanoma.
Dermatology Times – Dermatology
Category Archives: Eczema On Face Treatment
How deep an SCC lies within the skin correlates to lesion length
This study, which may have direct implications for treatment, explains why some actinic keratoses recur and progress after superficial destructive treatments — like cryotherapy.
Dermatology Times – Dermatology
A single drug may control skin cancer treatment costs
A $ 78 single course of topical fluorouracil for keratinocyte carcinoma and actinic keratosis lesions, could lead to a savings in the hundreds of dollars in follow-up costs.
Dermatology Times – Dermatology
Healthcare in the cloud
Today, medical practices are considering cloud services for everything from revenue cycle management to patient engagement tools. HIMSS Analytics reports that the number of healthcare provider organizations planning to use the cloud for back office functions has jumped from 22-46% within two years.
Dermatology Times – Dermatology
What is micellar water?
Of all acne light therapies, one rises to the top
Researchers writing in JAMA Dermatology say that the evidence for light therapies as effective acne treatments remains weak and inconclusive, but one may be worth noting.
Dermatology Times – Dermatology
Patients rate acne scar subcision techniques
Doctors writing in the Journal of Cosmetic Dermatology find blunt cannula subcision (BCS) more effective than Nokor needle subcision (NNS) for acne scarring.
Dermatology Times – Dermatology
What’s your digital style?
Filaggrin degradation products may explain higher rate of dermatitis in the winter
A decrease in the levels of natural moisturizing factors and an increase in the density of corneocytes may explain why dermatitis and xerosis are worse in the winter.
Dermatology Times – Dermatology
Biosimilars safety performance in psoriasis
A study that compares the safety, efficacy and drug survival of biologics to biosimilars, finds that switching to a biosimilar had no significant impact on drug survival or safe
Dermatology Times – Dermatology